Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Open in Screener

BHVN

Biohaven Ltd

Oct 23 • 10:15AM ET

51.80

Dollar change -0.85
Percentage change -1.62	%

Healthcare • Biotechnology • USA • NYSE

Peers: VRTX AMGN REGN GILD BMRN NBIX ALNY INCY SRPT EXEL

| Held by: VTI IWM VB XBI VBR VXF IWO IBB SCHA VTWO

Index	RUT	P/E	-	EPS (ttm)	-9.16	Insider Own	12.91%	Shs Outstand	94.54M	Perf Week	0.64%
Market Cap	4.90B	Forward P/E	-	EPS next Y	-6.33	Insider Trans	4.88%	Shs Float	82.34M	Perf Month	15.01%
Income	-746.61M	PEG	-	EPS next Q	-1.70	Inst Own	88.28%	Short Float	10.90%	Perf Quarter	28.72%
Sales	0.00M	P/S	-	EPS this Y	-52.93%	Inst Trans	13.71%	Short Ratio	9.02	Perf Half Y	33.78%
Book/sh	4.16	P/B	12.47	EPS next Y	27.72%	ROA	-137.07%	Short Interest	8.98M	Perf Year	92.92%
Cash/sh	4.62	P/C	11.20	EPS next 5Y	-	ROE	-193.67%	52W Range	25.97 - 62.21	Perf YTD	21.03%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-182.13%	52W High	-16.74%	Beta	4.12
Dividend TTM	-	Quick Ratio	3.27	Sales past 5Y	0.00%	Gross Margin	-	52W Low	99.46%	ATR (14)	2.41
Dividend Ex-Date	-	Current Ratio	3.27	EPS Y/Y TTM	-44.95%	Oper. Margin	0.00%	RSI (14)	58.55	Volatility	4.41% 5.15%
Employees	239	Debt/Eq	0.08	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.13	Target Price	64.31
Option/Short	Yes / Yes	LT Debt/Eq	0.07	EPS Q/Q	-175.22%	Payout	-	Rel Volume	0.54	Prev Close	52.65
Sales Surprise	-	EPS Surprise	-104.41%	Sales Q/Q	-	Earnings	Aug 08 AMC	Avg Volume	995.45K	Price	51.80
SMA20	1.46%	SMA50	16.98%	SMA200	19.68%	Trades		Volume	85,634	Change	-1.62%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-16-24	Initiated	Jefferies	Buy	$57
Sep-04-24	Initiated	Bernstein	Outperform	$55
Jul-24-24	Initiated	Morgan Stanley	Overweight	$58
Feb-16-24	Initiated	RBC Capital Mkts	Outperform	$62
Feb-06-24	Initiated	UBS	Buy	$59
Dec-22-23	Initiated	H.C. Wainwright	Buy	$50
Dec-08-23	Initiated	Robert W. Baird	Outperform	$58
Jan-24-23	Initiated	SVB Securities	Outperform	$24
Jan-04-23	Initiated	JP Morgan	Overweight	$23
Dec-02-22	Initiated	BTIG Research	Buy	$24
Oct-26-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$158 → $27
Oct-12-22	Initiated	Piper Sandler	Overweight	$23
Aug-19-22	Downgrade	Piper Sandler	Overweight → Neutral	$149
Aug-08-22	Downgrade	Wedbush	Outperform → Neutral	$148.50
May-11-22	Downgrade	SVB Leerink	Outperform → Mkt Perform	$150
Oct-19-21	Resumed	Morgan Stanley	Equal-Weight	$107 → $145
Aug-10-21	Downgrade	UBS	Buy → Neutral	$108 → $109
Aug-03-21	Reiterated	Canaccord Genuity	Buy	$101 → $150
Mar-11-21	Initiated	UBS	Buy	$108
Dec-15-20	Initiated	H.C. Wainwright	Buy	$121

Show Previous Ratings

Oct-07-24 04:13PM	Scholar Rock Jumps 362% On Final-Phase Win In Spinal Muscular Atrophy (Investor's Business Daily) +10.75%
09:41AM	Scholar Rock Catapults By Triple Digits On Final-Phase Win In Spinal Muscular Atrophy (Investor's Business Daily)
Oct-02-24 04:05PM	Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire)
Oct-01-24 06:00AM	Biohaven Announces Pricing of $250 Million Public Offering of Common Shares (PR Newswire)
Sep-30-24 04:05PM	Biohaven Announces Proposed Public Offering of Common Shares (PR Newswire)
07:30AM	Loading…
07:30AM	Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine (PR Newswire)
Sep-23-24 07:30AM	Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA) (PR Newswire) +13.74%
Sep-20-24 07:09PM	Biohaven Announces Conference Call to Discuss Topline Pivotal Study Results in Spinocerebellar Ataxia (PR Newswire)
Aug-08-24 08:21PM	Do Analysts Think That Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Is a Good GLP-1 and Weight Loss Stock to Invest In? (Insider Monkey) +5.93% +6.25%
04:05PM	Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments (PR Newswire)
Jul-01-24 07:00AM	Benitec Biopharma Announces Appointment of Kishen Mehta to its Board of Directors (GlobeNewswire)
Jun-28-24 10:00AM	The 3 Smartest Healthcare Stocks to Buy With $1K Right Now (InvestorPlace)
May-29-24 07:30AM	Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day (PR Newswire) -12.57%
07:15AM	Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors (PR Newswire)
May-15-24 11:00AM	Director Gregory Bailey Acquires 15,000 Shares of Biohaven Ltd (BHVN) (GuruFocus.com)
09:35AM	Loading…
May-14-24 09:35AM	Down -24.55% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround (Zacks) +10.24%
May-13-24 09:35AM	Down -32.76% in 4 Weeks, Here's Why Biohaven Ltd. (BHVN) Looks Ripe for a Turnaround (Zacks) -5.35%
May-09-24 11:54PM	BHVN Stock Earnings: Biohaven Misses EPS for Q1 2024 (InvestorPlace) -13.71%
04:05PM	Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments (PR Newswire)
May-01-24 02:38PM	Shhh! 3 Secret Biotech Stocks Flying Below Wall Street's Radar (InvestorPlace)
Apr-26-24 06:00AM	3 Biotech Stocks to Buy on the Dip: April 2024 (InvestorPlace)
Apr-25-24 11:00AM	Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN) (GuruFocus.com)
Apr-23-24 11:00AM	Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN) (GuruFocus.com)
Apr-22-24 04:05PM	Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire)
Apr-18-24 06:00AM	Biohaven Announces Pricing of $230 Million Public Offering of Common Shares (PR Newswire)
Apr-17-24 04:05PM	Biohaven Announces Proposed Public Offering of Common Shares (PR Newswire)
Apr-13-24 09:00AM	Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates (PR Newswire)
Apr-03-24 10:03PM	LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside? (TipRanks)
Feb-29-24 04:05PM	Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments (PR Newswire)
Jan-25-24 05:31PM	Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs (InvestorPlace)
07:00AM	Loading…
Jan-22-24 07:00AM	Obesity Drugs Lead to Muscle LossPharma Companies Want to Fix That (The Wall Street Journal) +9.24%
Jan-08-24 07:30AM	Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and Oncology (PR Newswire) +10.50%
Jan-02-24 07:00AM	Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-31-23 03:01AM	Director Irina Antonijevic Sells 11,000 Shares of Biohaven Ltd (BHVN) (GuruFocus.com)
Dec-01-23 04:30PM	Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual Meeting (PR Newswire)
Nov-16-23 09:40AM	Is Biohaven Ltd. (BHVN) Outperforming Other Medical Stocks This Year? (Zacks)
Nov-14-23 09:15PM	Biohaven Ltd (BHVN) Reports Q3 2023 Financial Results: Advances in Clinical Programs and Strong ... (GuruFocus.com)
04:05PM	Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments (PR Newswire)
Nov-06-23 08:50AM	Biohaven Ltd. (BHVN) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks) -6.39%
Oct-31-23 09:40AM	Are Medical Stocks Lagging Biohaven Ltd. (BHVN) This Year? (Zacks)
Oct-19-23 08:50AM	Here's Why Momentum in Biohaven Ltd. (BHVN) Should Keep going (Zacks)
Oct-16-23 07:00AM	Biohaven Presents Preclinical Data Demonstrating Taldefgrobep alfa Reduces Fat and Improves Lean Mass at The Obesity Society's Annual Meeting, ObesityWeek (PR Newswire)
Oct-06-23 01:01PM	Insider Buying: CFO Matthew Buten Acquires 22,727 Shares of Biohaven Ltd (BHVN) (GuruFocus.com)
Oct-05-23 04:05PM	Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire) +5.32%
Oct-03-23 08:50AM	Here's What Could Help Biohaven Ltd. (BHVN) Maintain Its Recent Price Strength (Zacks)
Oct-02-23 11:56PM	Biohaven Announces Pricing of $225 Million Public Offering of Common Shares (PR Newswire) -7.46%
04:36PM	BIOHAVEN ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES (PR Newswire)
Sep-29-23 10:00AM	Small Biotech Stocks Haven't Shined of Late, but I Think These 3 Could Be Stars (TheStreet.com)
10:00AM	3 Small Biotech Stocks That Could Be Stars (TheStreet.com)
Sep-28-23 07:53AM	Biohaven (BHVN) Up on Positive Data from Autoimmune Disease Drug (Zacks) +10.54%
Sep-27-23 04:09PM	Biohaven, Yet Another Rival To Argenx In Autoimmune Drugs, Just Rocketed 33% (Investor's Business Daily) +33.31%
12:25PM	Biohaven, Yet Another Argenx Rival In Autoimmune Drugs, Just Rocketed 29% (Investor's Business Daily)
12:00PM	Why Biohaven Stock Is Skyrocketing Today (Motley Fool)
Sep-14-23 07:00AM	Biohaven Completes Enrollment in Pivotal Phase 3 Study of Taldefgrobep Alfa in Spinal Muscular Atrophy (PR Newswire)
Sep-05-23 07:00AM	Biohaven Announces Positive Data from its Exploratory Electroencephalogram (EEG) Biomarker Study of BHV-7000, Completion of Once-Daily Formulation Development, and Plan to Initiate Phase 3 Pivotal Studies (PR Newswire) -6.18%
Aug-09-23 06:01AM	Independent Director of Biohaven Picks Up 1.8% More Stock (Simply Wall St.)
Jul-31-23 09:31AM	Biohaven's Taldefgrobep Alfa Receives EU Orphan Drug Designation for Spinal Muscular Atrophy (PR Newswire)
06:59AM	Biohaven Reports Second Quarter 2023 Financial Results and Recent Business Developments (PR Newswire)
Jul-27-23 12:50PM	Why Biohaven Stock Is Crashing Today (Motley Fool) -22.61%
07:00AM	Biohaven Provides Preliminary EEG Data Update for Kv7 Platform, Regulatory Update on Troriluzole and Other Corporate Updates (PR Newswire)
Jun-27-23 05:31AM	2 Growth Stocks With Major Incoming Catalysts (Motley Fool)
Jun-02-23 09:11AM	Why Biohaven Stock Caught Fire This Week (Motley Fool)
Jun-01-23 04:08PM	Biohaven, A Top 2% Stock, Exits 'Stealth Mode' And Hits A Record High (Investor's Business Daily) +18.39%
01:01PM	How Biohaven Is Coming 'Out Of Stealth Mode' And Bullishly Extending A 4-Day Run (Investor's Business Daily)
11:29AM	Biohaven (BHVN) Stock up 8% on Encouraging Pipeline Updates (Zacks)
May-31-23 07:00AM	Biohaven Provides Overview of Clinical Progress, Regulatory Updates, and Pipeline Developments at R&D Day (PR Newswire) +7.56%
May-25-23 05:00PM	Biohaven to Present R&D Day at Yale School of Management (PR Newswire)
May-24-23 01:30PM	These Small-Cap Biotech Stocks Have the Wind at Their Back (TheStreet.com) -5.34%
May-12-23 04:30PM	Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business Developments (PR Newswire) +6.91%
May-05-23 10:43AM	Is Biohaven (NYSE:BHVN) In A Good Position To Deliver On Growth Plans? (Simply Wall St.)
Apr-17-23 07:00AM	Biohaven Expands Executive Leadership Team with Appointment of Nick Kozauer M.D. as Senior Vice President for Clinical Development and Regulatory Strategy (PR Newswire) +9.01%
Mar-30-23 09:40AM	Is Biohaven Ltd. (BHVN) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-25-23 09:22AM	Bullish Biohaven Ltd. (NYSE:BHVN) insiders filled their treasuries with US$37m worth of stock over last year (Simply Wall St.)
Mar-23-23 04:05PM	Biohaven Reports Fourth Quarter and Full Year 2022 Financial Results and Reports Recent Business Developments (PR Newswire) +6.64%
11:09AM	Biohaven (BHVN) Acquires Dual Inhibitor for Brain Disorders (Zacks)
Mar-22-23 07:30AM	Biohaven Acquires Exclusive License for Oral, Brain-Penetrant, Dual TYK2/JAK1 Inhibitor for Immune-Mediated Brain Disorders (PR Newswire) -5.89%
Mar-14-23 07:30AM	Biohaven Announces Presentation at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting (PR Newswire)
Mar-13-23 11:39AM	Pfizer (PFE) Gets FDA Nod for Migraine Nasal Spray Zavzpret (Zacks) +7.48%
Feb-23-23 08:36AM	Why Earnings Season Could Be Great for Biohaven (BHVN) (Zacks)
Feb-21-23 07:30AM	Biohaven's Taldefgrobep Alfa Receives FDA Fast Track Designation for Spinal Muscular Atrophy (PR Newswire) -7.69%
Feb-10-23 02:55PM	JPMorgans Best Performing 15 Stock Picks for 2023 (Insider Monkey)
Feb-02-23 12:52PM	Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric (Investor's Business Daily)
Jan-06-23 07:58AM	J.P. Morgan Says These 2 Stocks Are Ready to Rip Higher This Is What Makes Them Attractive Buys (TipRanks)
07:30AM	Biohaven to Present at the 41st Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-05-23 09:40AM	Is Biohaven Ltd. (BHVN) Outperforming Other Medical Stocks This Year? (Zacks) -5.94%
Dec-23-22 06:21AM	Biohaven Ltd.'s (NYSE:BHVN) market cap dropped US$151m last week; individual investors who hold 55% were hit as were institutions (Simply Wall St.) +6.44%
Nov-29-22 09:35AM	After Plunging 13% in 4 Weeks, Here's Why the Trend Might Reverse for Biohaven Ltd. (BHVN) (Zacks) +6.87%
Nov-28-22 09:55AM	How Much Upside is Left in Biohaven Ltd. (BHVN)? Wall Street Analysts Think 54% (Zacks) -9.09%
Nov-21-22 09:33AM	George Soros Pulls the Trigger on These 2 Strong Buy Stocks (TipRanks)
Nov-09-22 08:35AM	Biohaven Ltd. (BHVN) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -5.33%
07:00AM	Biohaven Ltd. Reports Third Quarter 2022 Financial Results and Reports Recent Business Developments (PR Newswire)
Nov-08-22 11:52AM	George Soros Stock Portfolio: Top 10 Stock Picks (Insider Monkey)
Nov-06-22 11:48AM	3 Hot Insider Trades, Plus Hedge Fund Moves: Coca-Cola, Biohaven, Carl Icahn (Investing.com)
07:00AM	Call This an Off-Label Trade (TheStreet.com)
Nov-01-22 10:01AM	Biohaven Ltd. (BHVN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-25-22 08:21PM	Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire) -5.55%
04:30PM	Biohaven Advances Development of the MoDE Platform Technology Licensed From Yale University (PR Newswire)
Oct-20-22 10:30PM	Biohaven Announces Pricing of Public Offering of Common Shares (PR Newswire) +17.73%
Oct-18-22 04:12PM	Biohaven Announces Launch of Public Offering of Common Shares (PR Newswire) +18.32%
Oct-07-22 03:24AM	Biohaven Ltd. (BHVN) Surges 7.6%: Is This an Indication of Further Gains? (Zacks)

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
CHILDS JOHN W	Director	Oct 02 '24	Buy	47.50	21,052	999,970	21,052	Oct 03 07:01 AM
Coric Vlad	Chief Executive Officer	Oct 02 '24	Buy	47.50	21,052	999,970	861,942	Oct 03 07:00 AM
Bailey Gregory	Director	Sep 24 '24	Buy	44.19	5,000	220,966	1,620,071	Sep 25 07:30 AM
CHILDS JOHN W	Director	Jul 18 '24	Buy	35.67	28,400	1,012,983	2,339,741	Jul 19 08:56 AM
Car Bruce	Chief Scientific Officer	Jun 17 '24	Buy	33.58	30,000	1,007,490	30,000	Jun 20 07:30 AM
CHILDS JOHN W	Director	May 30 '24	Buy	35.58	28,000	996,240	2,311,341	May 31 09:04 AM
Bailey Gregory	Director	May 13 '24	Buy	34.19	15,000	512,877	1,615,071	May 15 07:31 AM
CHILDS JOHN W	Director	May 13 '24	Buy	35.17	28,500	1,002,470	2,283,341	May 14 07:30 AM
Bailey Gregory	Director	Apr 24 '24	Buy	39.18	25,503	999,169	1,600,071	Apr 25 07:32 AM
Bailey Gregory	Director	Apr 22 '24	Buy	41.00	48,780	1,999,980	1,574,568	Apr 23 07:54 AM
CHILDS JOHN W	Director	Apr 22 '24	Buy	41.00	195,121	7,999,961	4,096,512	Apr 23 07:54 AM
Coric Vlad	Chief Executive Officer	Apr 22 '24	Buy	41.00	121,951	4,999,991	1,788,417	Apr 23 07:54 AM
Antonijevic Irina	Director	Dec 29 '23	Option Exercise	0.00	11,000	0	13,535	Dec 29 06:25 PM
Antonijevic Irina	Director	Dec 29 '23	Sale	41.79	11,000	459,662	2,535	Dec 29 06:25 PM

Open in Screener

SER

Serina Therapeutics Inc.

Oct 23 • 09:54AM ET

7.66

Dollar change +0.01
Percentage change 0.13	%

Healthcare • Biotechnology • USA • AMEX

SER Serina Therapeutics Inc. daily Stock Chart

Peers: MRK LLY BMY JNJ AMGN PFE GILD REGN VRTX BIIB

Index	-	P/E	-	EPS (ttm)	-11.08	Insider Own	54.91%	Shs Outstand	8.88M	Perf Week	1.32%
Market Cap	68.02M	Forward P/E	-	EPS next Y	-	Insider Trans	2.05%	Shs Float	4.00M	Perf Month	2.13%
Income	-13.09M	PEG	-	EPS next Q	-	Inst Own	2.32%	Short Float	0.81%	Perf Quarter	-16.28%
Sales	0.18M	P/S	377.89	EPS this Y	-	Inst Trans	25.89%	Short Ratio	2.03	Perf Half Y	-34.50%
Book/sh	-1.86	P/B	-	EPS next Y	-	ROA	-113.90%	Short Interest	0.03M	Perf Year	-69.75%
Cash/sh	0.68	P/C	11.22	EPS next 5Y	-	ROE	-	52W Range	5.85 - 24.62	Perf YTD	-43.43%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-12.67%	ROI	-	52W High	-68.89%	Beta	1.04
Dividend TTM	-	Quick Ratio	0.71	Sales past 5Y	-39.80%	Gross Margin	-1.68%	52W Low	30.94%	ATR (14)	0.61
Dividend Ex-Date	-	Current Ratio	0.71	EPS Y/Y TTM	-6.88%	Oper. Margin	-6761.45%	RSI (14)	55.41	Volatility	7.29% 8.58%
Employees	4	Debt/Eq	-	Sales Y/Y TTM	397.22%	Profit Margin	-7312.85%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	120.72%	Payout	-	Rel Volume	0.45	Prev Close	7.65
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	466.67%	Earnings	-	Avg Volume	15.96K	Price	7.66
SMA20	7.35%	SMA50	5.34%	SMA200	-25.93%	Trades		Volume	1,140	Change	0.13%

Oct-02-24 08:30AM	Serina Therapeutics to Present at the 14th Annual Injectables Summit (GlobeNewswire)
Sep-04-24 06:42PM	Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-20-24 07:01PM	Director Gregory Bailey Acquires 19,200 Shares of Serina Therapeutics Inc (SER) (GuruFocus.com)
Aug-09-24 04:15PM	Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights (GlobeNewswire) -5.17% -10.13%
Jul-29-24 08:30AM	Serina Therapeutics to Present Novel Data on POZ-Lipid Technology Potentially Enhancing Safety and Efficacy of mRNA LNP Formulations at the 4th mRNA-Based Therapeutics Summit (GlobeNewswire)
05:00PM	Loading…
Jul-18-24 05:00PM	Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation (GlobeNewswire) -18.15% +9.84%
May-15-24 07:30AM	Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinsons Disease (GlobeNewswire)
May-14-24 04:05PM	Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights (GlobeNewswire) +11.13%
Apr-17-24 04:05PM	Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman (GlobeNewswire) -9.64%
Mar-26-24 05:04PM	Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics (GlobeNewswire) -11.90% +33.98%

Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bailey Gregory	Director	Sep 20 '24	Buy	6.03	1,137	6,851	63,377	Sep 24 04:30 PM
Bailey Gregory	Director	Sep 19 '24	Buy	6.11	11,679	71,384	62,240	Sep 20 06:59 PM
Bailey Gregory	Director	Sep 18 '24	Buy	6.23	2,709	16,873	50,561	Sep 20 06:59 PM
MINTZ STEVEN	Director	Sep 12 '24	Buy	6.47	6,000	38,814	17,443	Sep 16 06:53 PM
Bailey Gregory	Director	Aug 20 '24	Buy	8.25	1,776	14,652	47,582	Aug 22 05:27 PM
Bailey Gregory	Director	Aug 19 '24	Buy	7.93	6,400	50,760	45,806	Aug 20 04:35 PM
Bailey Gregory	Director	Aug 16 '24	Buy	7.31	6,400	46,780	39,406	Aug 20 04:35 PM
Bailey Gregory	Director	Aug 15 '24	Buy	6.65	6,400	42,577	33,006	Aug 20 04:35 PM
MINTZ STEVEN	Director	Aug 15 '24	Buy	6.59	7,593	50,033	11,443	Aug 19 06:55 PM
MINTZ STEVEN	Director	Aug 15 '24	Buy	6.59	1,350	8,896	12,257	Aug 19 06:55 PM
Bailey Gregory	Director	Aug 14 '24	Buy	7.07	6,400	45,228	26,606	Aug 16 04:20 PM
MINTZ STEVEN	Director	Jun 21 '24	Buy	9.50	5,000	47,500	8,307	Jun 27 08:26 PM
MINTZ STEVEN	Director	Jun 25 '24	Buy	9.00	2,600	23,400	10,907	Jun 27 08:26 PM
Bailey Gregory	Director	May 30 '24	Buy	9.50	5,205	49,448	20,206	May 31 04:18 PM
Bailey Gregory	Director	May 29 '24	Buy	9.50	1,173	11,144	15,001	May 31 04:18 PM
Bailey Gregory	Director	May 28 '24	Buy	9.50	9,019	85,680	13,828	May 29 04:15 PM
Bailey Gregory	Director	May 23 '24	Buy	9.50	2,371	22,524	4,809	May 24 04:15 PM
Bailey Gregory	Director	May 21 '24	Buy	9.50	916	8,702	2,438	May 24 04:15 PM
MINTZ STEVEN	Director	May 21 '24	Buy	9.93	9,151	90,885	9,900	May 23 05:07 PM
MINTZ STEVEN	Director	May 20 '24	Buy	9.43	2,675	25,233	1,240	May 23 05:07 PM
MINTZ STEVEN	Director	May 17 '24	Buy	8.50	554	4,709	554	May 23 05:07 PM
Bailey Gregory	Director	May 21 '24	Buy	9.50	1,422	13,509	1,522	May 23 04:15 PM
Bailey Gregory	Director	May 20 '24	Buy	9.00	100	900	100	May 22 04:15 PM

BHVN

Biohaven Ltd

SER

Serina Therapeutics Inc.

Upgrade your FINVIZ experience